Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine, Busulfan, and Thymoglobulin (CBT) Conditioning Prior to Allo-SCT in High-risk AML, MDS, or ALL
NCT00863148Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Oct 2009
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (ALL), sponsored by CHU de Nantes. Started Oct 2009; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00863148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863148.